Pharmacotherapy of Chronic Neuropsychiatric Conditions During Pregnancy

Sarah M. Westberg, Regina Arellano, Nicole E. Cieri-Hutcherson, Natalie T. Heinrich, Alexandra M. Herman, Nicole M. Lodise, Sarah McBane, Theresa U. Ofili, Niamh O'Grady, Kjersten H. Sankey

Research output: Contribution to journalArticlepeer-review

Abstract

Many pregnant persons will experience neuropsychiatric conditions during pregnancy, including migraine, attention deficit disorder, depression, and anxiety. Treatment of each of these conditions requires shared decision-making among the individual, family, and health care team. Although medications may include risk, the benefits often outweigh the potential fetal risks. In this article, we review pharmacologic treatment options for each of these conditions and appropriate use in pregnancy to maintain the stability of conditions and to optimize maternal and fetal outcomes.

Original languageEnglish (US)
Pages (from-to)227-241
Number of pages15
JournalNursing for Women's Health
Volume28
Issue number3
DOIs
StatePublished - Jun 2024

Bibliographical note

Publisher Copyright:
© 2024 AWHONN

Keywords

  • ADHD
  • anxiety
  • attention deficit disorder
  • depression
  • major depressive disorder
  • medication
  • migraine
  • neuropsychiatric
  • pharmacotherapy
  • pregnancy

PubMed: MeSH publication types

  • Journal Article
  • Review

Fingerprint

Dive into the research topics of 'Pharmacotherapy of Chronic Neuropsychiatric Conditions During Pregnancy'. Together they form a unique fingerprint.

Cite this